Nivolumab in combination therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nivolumab in combination therapy, covering 2022-04-12 to 2022-04-12. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors [Phase 1, Phase 2]